Myelofibrosis and Essential Thrombocythemia Observational Study - Adventist HealthCare

Skip to Content

Clinical Trial Details


Myelofibrosis and Essential Thrombocythemia Observational Study


Request Additional Trial Information
Full Trial Details:

Condition: Cancer
Study Type: Interventional
Phase: Phase II
Study Start Date: 12/01/2016
Study Completion Date: 12/31/2021

The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia (ET) or myelofibrosis (MF).

NCT Number
Principal Investigator(s)
John Wallmark, MD
Incyte Corporation
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Male, Female


  • Shady Grove Adventist Aquilino Cancer Center
    9905 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6297

Clincal Trials & Research Studies

Patient Stories

We’re writing new chapters in the lives of our patients, their families and our community daily. These are their stories:

Local Health News - In Your Inbox

Join over 80k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!